Evidence map›Paper›PMID 34443595›Full record

ArticleMolecules (Basel, Switzerland)2021

In Vitro Anti-

Monika Staniszewska, Łukasz Kuryk, Aleksander Gryciuk, Joanna Kawalec, Marta Rogalska, Joanna Baran, Edyta Łukowska-Chojnacka, Anna Kowalkowska

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Novel Metabolites ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Emerging Antifungal Targets and Strategies.International journal of molecular sciences · 2022
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Monika StaniszewskaCentre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Poleczki 19, 02-822 Warsaw, Poland.
Łukasz KurykDepartment of Virology, National Institute of Public Health-NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.ORCID 0000-0003-1887-6361
Aleksander GryciukFaculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland.
Joanna KawalecFaculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland.ORCID 0000-0001-5335-4433
Marta RogalskaFaculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland.
Joanna BaranCentre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Poleczki 19, 02-822 Warsaw, Poland.
Edyta Łukowska-ChojnackaFaculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland.ORCID 0000-0002-9512-7404
Anna KowalkowskaFaculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland.
Warsaw University of Technology · PLNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A newly synthetized series of

Indexed as

Antifungal AgentsBenzoxazolesCandida albicansMicrobial Sensitivity TestsCandidaDrug Resistance, FungalHumansMolecular StructureStructure-Activity RelationshipAntifungal AgentsBenzoxazolesaction modebenzoxazoleCandida spp.in vitroN-phenacyl

Identifiers

PMID34443595
PMCPMC8398596
OpenAlexW3194285853

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.